跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANDESARTAN HCTZ-WGR 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
CANDESARTAN HCTZ-WGR 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Approved
STANDARD
CANDESARTAN HCTZ-WGR 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack
GM Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
135a43d16d6ffcbb
Company
GM Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
135a43d16d6ffcbb
Product Name
CANDESARTAN HCTZ-WGR 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Artg Id
253613
Artg Name
CANDESARTAN HCTZ-WGR 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack
Sponsor
GM Pharma International Pty Ltd
Company Detail Path
/organization/gm-pharma-international-pty-ltd
Artg Date
2015-10-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4c924d7412c03347bbbbad47507d4eab.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2e0477d9e9e9c54c168bb7cf56076b4b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
135a43d16d6ffcbb
Type
Standard
Back to TGA Approvals